Kambiz Yazdi
Stock Analyst at BTIG
(2.68)
# 2,867
Out of 5,082 analysts
88
Total ratings
39.4%
Success rate
2.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Maintained: Buy | $57 | $27.69 | +105.85% | 10 | Oct 22, 2026 | |
| KZIA Kazia Therapeutics | Maintained: Buy | $40 | $6.79 | +489.10% | 6 | Oct 22, 2026 | |
| ABSI Absci | Reiterated: Buy | $16 | $8.74 | +83.07% | 8 | Oct 6, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $810 → $826 | $239.02 | +245.58% | 16 | Oct 6, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $75 | $28.33 | +164.74% | 13 | Oct 1, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $4.09 | - | 9 | Aug 10, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $24 | $10.23 | +134.60% | 6 | Aug 5, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €67.30 | +79.79% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Reiterated: Buy | $31 | $26.41 | +17.38% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $33.94 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $11.84 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.01 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.24 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $0.98 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0005 | n/a | 1 | May 31, 2023 |
vTv Therapeutics
Oct 22, 2026
Maintained: Buy
Price Target: $57
Current: $27.69
Upside: +105.85%
Kazia Therapeutics
Oct 22, 2026
Maintained: Buy
Price Target: $40
Current: $6.79
Upside: +489.10%
Absci
Oct 6, 2026
Reiterated: Buy
Price Target: $16
Current: $8.74
Upside: +83.07%
Praxis Precision Medicines
Oct 6, 2026
Rated: Buy
Price Target: $810 → $826
Current: $239.02
Upside: +245.58%
Rapport Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $75
Current: $28.33
Upside: +164.74%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.09
Upside: -
Zevra Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $24
Current: $10.23
Upside: +134.60%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €67.30
Upside: +79.79%
Arcutis Biotherapeutics
Jan 15, 2026
Reiterated: Buy
Price Target: $31
Current: $26.41
Upside: +17.38%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $33.94
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $11.84
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $15
Current: $3.01
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.24
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $15 → $14
Current: $0.98
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0005
Upside: n/a